Short interest in Protalix BioTherapeutics Inc (AMEX:PLX) increased during the last reporting period, rising from 3.10M to 3.10M. This put 4.41% of the company's publicly available shares short.

Short interest for Protalix BioTherapeutics gives investors a sense of the degree to which investors are betting on the decline of Protalix BioTherapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 142.90K shares traded per day, it would take 21.68 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.